Efficacy of hepatitis B sero-vaccination in newborns of African HBsAg positive mothers

Vaccine

Volumn 29, Issue 16, 2011, Pages 2846-2849

  Chakvetadze, Catherine ^a,b   Roussin, Céline ^d   Roux, Jonathan ^d   Mallet, Vincent ^a,b,c   Petinelli, M E ^d   Pol, Stanislas ^a,b,c  

^a UNIVERSITÉ PARIS DESCARTES   (France)

^b ASSISTANCE PUBLIQUE HÔPITAUX DE PARIS   (France)

^c INSTITUT COCHIN   (France)

^d CENTRE HOSPITALIER DE MAYOTTE   (France)

Author keywords

Hepatitis B; Immunoprophylaxis; Maternal infant transmission of hepatitis B virus

Indexed keywords

HEPATITIS B SURFACE ANTIGEN; HEPATITIS B VACCINE; IMMUNOGLOBULIN; VIRUS DNA;

ADULT; ARTICLE; CHILD; CLINICAL ARTICLE; FEMALE; HEPATITIS B; HUMAN; IMMUNOPROPHYLAXIS; MATERNAL AGE; NEWBORN; PRESCHOOL CHILD; PRIORITY JOURNAL; SCHOOL CHILD; VACCINATION; VERTICAL TRANSMISSION; VIRUS LOAD;

ADULT; COMOROS; FEMALE; HEPATITIS B; HEPATITIS B ANTIBODIES; HUMANS; IMMUNIZATION SCHEDULE; IMMUNIZATION, PASSIVE; INFANT, NEWBORN; INFECTIOUS DISEASE TRANSMISSION, VERTICAL; PREGNANCY; PREGNANCY COMPLICATIONS, INFECTIOUS; RETROSPECTIVE STUDIES; TREATMENT OUTCOME; VIRAL LOAD; YOUNG ADULT;

EID: 79953232330     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vaccine.2011.01.101     Document Type: Article

References (17)

1. Sinha S, Kumar M. Pregnancy and chronic hepatitis B virus infection. Hepatol Res. 2010 Jan; 40(1): 31-48.
2. Beasley R.P., et al. Evidence against breast-feeding as a mechanism for vertical transmission of hepatitis B. Lancet 1975, 2(7938):740-741.
3. Hyams K.C. Risks of chronicity following acute hepatitis B virus infection: a review. Clin. Infect. Dis. 1995, 20(4):992-1000.
4. Goldstein S.T., Zhou F., Hadler S.C., Bell B.P., Mast E.E., Margolis H.S. A mathematical model to estimate global hepatitis B disease burden and vaccination impact. Int. J. Epidemiol. 2005, 34(6):1329-1339.
5. Prevention of perinatal transmission of hepatitis B virus: prenatal screening of all pregnant women for hepatitis B surface antigen. MMWR Morb Mortal Wkly Rep, 1988. 37(22): p. 341-6, 351.
6. Andre F.E., Zuckerman A.J. Review: protective efficacy of hepatitis B vaccines in neonates. J. Med. Virol. 1994, 44(2):144-151.
7. Xiao X.M., Li A.Z., Chen X., Zhu Y.K., Miao J. Prevention of vertical hepatitis B transmission by hepatitis B immunoglobulin in the third trimester of pregnancy. Int. J. Gynaecol. Obstet. 2007, 96(3):167-170.
8. Muszlak M., Lartigau-Roussin C., Farthouat L., Petinelli M., Hebert J.C., Santiago J. Vaccination of children against hepatitis B in Mayotte French Comoros Island. Arch. Pediatr. 2007, 14(9):1132-1136.
9. Vranckx R., Alisjahbana A., Meheus A. Hepatitis B virus vaccination and antenatal transmission of HBV markers to neonates. J. Viral Hepat. 1999, 6(2):135-139.
10. Song Y.M., Sung J., Yang S., Choe Y.H., Chang Y.S., Park W.S. Factors associated with immunoprophylaxis failure against vertical transmission of hepatitis B virus. Eur. J. Pediatr. 2007, 166(8):813-818.
11. Poovorawan Y., Sanpavat S., Chumdermpadetsuk S., Safary A. Long-term hepatitis B vaccine in infants born to hepatitis B e antigen positive mothers. Arch. Dis. Child. Fetal Neonatal Ed. 1997, 77(1):F47-51.
12. Lazizi Y., Badur S., Perk Y., Ilter O., Pillot J. Selective unresponsiveness to HBsAg vaccine in newborns related with an in utero passage of hepatitis B virus DNA. Vaccine 1997, 15(10):1095-1100.
13. Coursaget P., Yvonnet B., Gilks W.R., Wang C.C., Day N.E., Chiron J.P., et al. Scheduling of revaccination against hepatitis B virus. Lancet 1991, 337(8751):1180-1183.
14. Euler G.L., Copeland J.R., Rangel M.C., Williams W.W. Antibody response to postexposure prophylaxis in infants born to hepatitis B surface antigen-positive women. Pediatr Infect Dis J 2003, 22(2):123-129.
15. van Zonneveld M., van Nunen A.B., Niesters H.G., de Man R.A., Schalm S.W., Janssen H.L. Lamivudine treatment during pregnancy to prevent perinatal transmission of hepatitis B virus infection. J. Viral Hepat. 2003, 10(4):294-297.
16. Ekra D., Herbinger K.H., Konate S., Leblond A., Fretz C., Cilote V., et al. A non-randomized vaccine effectiveness trial of accelerated infant hepatitis B immunization schedules with a first dose at birth or age 6weeks in Cote d'Ivoire. Vaccine 2008, 26(22):2753-2761.
17. Selton D., André M., Gosselin J., Hascoet J.M. Efficacy of combined active-passive immunization in neonates born to hepatitis B surface antigen positive mothers: a study of 60 cases. J. Gynecol. Obstet. Biol. Reprod. (Paris) 2009, 38(6):500-509.